Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials 11-Jan-2021 By Rachel Arthur Codagenix’s intranasal COVID-19 vaccine has entered Phase 1 clinical trials: with the first volunteers dosed in the UK.